← Back to Dashboard

ZIKV

Zika virus

8
Approved Drugs
0
Phase 3
0
Phase 2
64
Preclinical
72
Total Compounds

Antiviral Compounds

Acetylsalicylic acidZIKVCyclooxygenase inhibitor
Preclinical
—Human COX
AmodiaquineZIKVMethyltransferase inhibitor
Preclinical
—Human HNMT
AnisomycinZIKVDNA synthesis inhibitor
Preclinical
—Human ribosome
AtovaquoneZIKVUnknown
Preclinical
—Human DHODH
AzaribineZIKVInhibition of Viral Genome Replication
Preclinical
—Viral RNA pol
AzauridineZIKVNucleoside analog
Preclinical
—Viral RNA pol
AzithromycinZIKV—
Preclinical
—Human (multiple)
BerberineZIKVAMP-activated protein kinase (AMPK) activator
Preclinical
—Unknown
Betulinic AcidZIKVUnknown
Preclinical
—Unknown
BithionolZIKVUncoupler of oxidative phosphorylation
Preclinical
—Unknown
BortezomibZIKVProteasome inhibitor (26S subunit)
Preclinical
—Human proteasome
ChloroquineZIKVAntimalaria agent; chemo/radio sensitizer
Preclinical
—Human (multiple)
ChlorpromazineZIKVInhibits assembly of clathrin-coated pits at the plasma membrane
Preclinical
—Human (multiple)
ClofazimineZIKVNon-nucleoside RT inhibitor
Preclinical
—Viral RNA pol
ClotrimazoleZIKVBlock Viral Entry (KCa3.1 antagonist)
Preclinical
—Human cytochrome P450
CR-1-31-BZIKVPrevents mRNA translation
Preclinical
—Human ATPase
Cucurbit[7]urilZIKVCompetitive binding of polyamines
Preclinical
—Human polyamines
CyclosporineZIKVCalcineurin inhibitor; allows for inhibition of T cell activation
Preclinical
—Human CYPs
DalbavancinZIKV—
Preclinical
—Unknown
DyphillinZIKVvacuolar ATPase inhibitors
Preclinical
—Human vATPase
EfavirenzZIKVInhibition of viral RT
Approved (other)
JapanRussia
Viral RNA pol
EflornithineZIKVEnzyme-activated; irreversible inhibitor of ornithine decarboxylase
Preclinical
—Human ODC
EmetineZIKV—
Preclinical
—Human ribosome
EmodinZIKV—
Preclinical
—Human (multiple)
EnoxacinZIKVDNA Topoisomerase II inhibitor
Preclinical
—Human topoisomerase
Showing 1 to 25 of 72 results
Page 1 of 3